Cargando…
Multidisciplinary Treatment of Non-Spine Bone Metastases: Results of a Modified Delphi Consensus Process
PURPOSE: Local treatment for bone metastases is becoming increasingly complex. National guidelines traditionally focus only on radiation therapy (RT), leaving a gap in clinical decision support resources available to clinicians. The objective of this study was to reach expert consensus regarding mul...
Autores principales: | Gillespie, Erin F., Mathis, Noah J., Vaynrub, Max, Santos Martin, Ernesto, Kotecha, Rupesh, Panoff, Joseph, Salner, Andrew L., McIntosh, Alyson F., Gupta, Ranju, Gulati, Amitabh, Yerramilli, Divya, Xu, Amy J., Bartelstein, Meredith, Guttmann, David M., Yamada, Yoshiya J., Lin, Diana, Lapen, Kaitlyn, Korenstein, Deborah, Pfister, David G., Lipitz-Snyderman, Allison, Yang, Jonathan T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127274/ https://www.ncbi.nlm.nih.gov/pubmed/35620018 http://dx.doi.org/10.1016/j.ctro.2022.04.009 |
Ejemplares similares
-
Assessment of Guideline-Nonconcordant Radiotherapy in Medicare Beneficiaries With Metastatic Cancer Near the End of Life, 2015-2017
por: Santos, Patricia Mae G., et al.
Publicado: (2022) -
Why Not? Persuading Clinicians to Reduce Overuse
por: Chimonas, Susan C., et al.
Publicado: (2020) -
Replacing 30 Gy in 10 fractions with stereotactic body radiation therapy for bone metastases: A large multi-site single institution experience 2016–2018
por: Gillespie, Erin F., et al.
Publicado: (2020) -
Should Postoperative Radiation for Long Bone Metastases Cover Part or All of the Orthopedic Hardware? Results of a Large Retrospective Analysis
por: Rosen, Daniel B., et al.
Publicado: (2021) -
Anti-IL17 antibody Secukinumab therapy is associated with ossification in giant cell tumor of bone: a case report of pathologic similarities and therapeutic potential similar to Denosumab
por: Chandler, Andrew, et al.
Publicado: (2021)